These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30575508)

  • 1. Cimzia™ (Certolizumab Pegol).
    Abramovits W; Wiqas A; Vincent KD; Versteeg SG; Gupta AK
    Skinmed; 2018; 16(6):400-402. PubMed ID: 30575508
    [No Abstract]   [Full Text] [Related]  

  • 2. Certolizumab pegol for the treatment of psoriasis.
    Campanati A; Benfaremo D; Luchetti MM; Ganzetti G; Gabrielli A; Offidani A
    Expert Opin Biol Ther; 2017 Mar; 17(3):387-394. PubMed ID: 28165828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized pustular psoriasis in pregnancy, successfully treated with certolizumab pegol.
    Mizutani Y; Mizutani YH; Matsuyama K; Kawamura M; Fujii A; Shu E; Ohnishi H; Seishima M
    J Dermatol; 2020 Jul; 47(7):e262-e263. PubMed ID: 32363682
    [No Abstract]   [Full Text] [Related]  

  • 4. Certolizumab Pegol in Plaque Psoriasis: Considerations for Pregnancy.
    Strain J; Leis M; Lee KO; Fleming P
    Skin Therapy Lett; 2021 Mar; 26(2):1-5. PubMed ID: 33769772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of Long-term Treatment With Certolizumab Pegol in Patients With Crohn's Disease, Based on a Pooled Analysis of Data From Clinical Trials.
    Loftus EV; Colombel JF; Schreiber S; Randall CW; Regueiro M; Ali T; Arendt C; Coarse J; Spearman M; Kosutic G
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1753-1762. PubMed ID: 27464588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of a patient with SAPHO syndrome with certolizumab pegol.
    Kamata Y; Minota S
    Rheumatol Int; 2015 Sep; 35(9):1607-8. PubMed ID: 25829226
    [No Abstract]   [Full Text] [Related]  

  • 7. Certolizumab pegol for the treatment of patients with moderate-to-severe chronic plaque psoriasis: pooled analysis of week 16 data from three randomized controlled trials.
    Blauvelt A; Reich K; Lebwohl M; Burge D; Arendt C; Peterson L; Drew J; Rolleri R; Gottlieb AB
    J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):546-552. PubMed ID: 30242918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT).
    Lebwohl M; Blauvelt A; Paul C; Sofen H; Węgłowska J; Piguet V; Burge D; Rolleri R; Drew J; Peterson L; Augustin M
    J Am Acad Dermatol; 2018 Aug; 79(2):266-276.e5. PubMed ID: 29660425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2).
    Gottlieb AB; Blauvelt A; Thaçi D; Leonardi CL; Poulin Y; Drew J; Peterson L; Arendt C; Burge D; Reich K
    J Am Acad Dermatol; 2018 Aug; 79(2):302-314.e6. PubMed ID: 29660421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of certolizumab pegol in chronic anterior uveitis associated to Crohn's disease and ankylosing spondylitis.
    Maiz Alonso O; Blanco Esteban AC; Egües Dubuc CA; Martinez Zabalegui D
    Reumatol Clin; 2015; 11(3):189-90. PubMed ID: 25555459
    [No Abstract]   [Full Text] [Related]  

  • 11. A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome.
    Bosch PC
    Eur Urol; 2018 Nov; 74(5):623-630. PubMed ID: 30072210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.
    Lee SD; Rubin DT; Sandborn WJ; Randall C; Younes Z; Schreiber S; Schwartz DA; Burakoff R; Binion D; Dassopoulos T; Arsenescu R; Gutierrez A; Scherl E; Kayhan C; Hasan I; Kosutic G; Spearman M; Sen D; Coarse J; Hanauer S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1870-80. PubMed ID: 27400222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Certolizumab Pegol: A Review in Inflammatory Autoimmune Diseases.
    Deeks ED
    BioDrugs; 2016 Dec; 30(6):607-617. PubMed ID: 27704400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Certolizumab Pegol in the Treatment of Psoriasis in a Cohort of Patients With Psoriatic Arthritis.
    Reina D; Vidal D
    Actas Dermosifiliogr (Engl Ed); 2020 Oct; 111(8):704-705. PubMed ID: 32593595
    [No Abstract]   [Full Text] [Related]  

  • 15. Institute for clinical and economic review (ICER) psoriasis update 2018: what it means for dermatologists treating moderate-to-severe plaque psoriasis.
    Lee EB; Pithadia DJ; Reynolds KA; Wu JJ
    J Dermatolog Treat; 2019 Dec; 30(8):772-774. PubMed ID: 30668188
    [No Abstract]   [Full Text] [Related]  

  • 16. Nail Psoriasis Treated With Certolizumab Pegol in Patients With Psoriatic Arthritis: Preliminary Observation.
    Mazzeo M; Dattola A; Cannizzaro MV; Bianchi L
    Actas Dermosifiliogr (Engl Ed); 2019 Mar; 110(2):169-171. PubMed ID: 29866366
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of certolizumab pegol to successfully treat generalized pustular psoriasis combined with psoriatic uveitis.
    Yatsuzuka K; Matsumoto T; Sakane Y; Fukaura R; Takeichi T; Akiyama M; Murakami M
    J Dermatol; 2023 Jun; 50(6):e175-e176. PubMed ID: 36585757
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary Cutaneous Nocardiosis in a Man Treated With Certolizumab.
    Gil Redondo R; Melgar Molero V; Martín Fuentes A; de Eusebio Murillo E
    Actas Dermosifiliogr (Engl Ed); 2019 Oct; 110(8):698-699. PubMed ID: 31133295
    [No Abstract]   [Full Text] [Related]  

  • 19. Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation.
    Corbett M; Chehadah F; Biswas M; Moe-Byrne T; Palmer S; Soares M; Walton M; Harden M; Ho P; Woolacott N; Bojke L
    Health Technol Assess; 2017 Oct; 21(56):1-326. PubMed ID: 28976302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Certolizumab].
    Charles J;
    Ann Dermatol Venereol; 2019; 146(6-7):487-491. PubMed ID: 31208736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.